Back to PFE Stock Lookup

Pfizer (PFE) – Press Releases

May 26, 2016 10:38 AM Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
May 23, 2016 07:00 AM CHAMPIX® (varenicline) European Union Label Updated to Include New Safety and Efficacy Data from the EAGLES Clinical Trial Following Endorsement from CHMP
May 20, 2016 08:00 AM Pfizer Announces European Medicines Agency Acceptance for Review of Marketing Authorization Application for TRUMENBA® (Meningococcal Group B Vaccine)
May 20, 2016 06:00 AM On BizWireTV: Streaming Service Finds Television and Climate Change on the Radar
May 19, 2016 08:30 AM Hospira Launches LifeCare PCA® 7.0 Infusion System, First PCA Pump That Integrates with the Electronic Medical Record
May 19, 2016 06:30 AM Spark Therapeutics and Pfizer Announce Data from Initial Subjects in Hemophilia B Trial Demonstrating Consistent Therapeutic Levels of Factor IX Expression
May 18, 2016 05:30 PM Merck KGaA, Darmstadt, Germany, and Pfizer to Present Avelumab Data in Seven Different Cancers at ASCO Annual Meeting
May 18, 2016 05:30 PM Merck and Pfizer to Present Avelumab Data in Seven Different Cancers at ASCO Annual Meeting
May 18, 2016 05:00 PM Pfizer to Showcase Diverse and Growing Oncology Portfolio at the American Society of Clinical Oncology (ASCO) 2016 Annual Meeting
May 17, 2016 08:00 AM Global Survey Finds Disconnects Between Physicians and People Living With Rheumatoid Arthritis (RA)
May 16, 2016 10:00 AM Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
May 16, 2016 06:45 AM Pfizer to Acquire Anacor
May 13, 2016 06:30 AM Pfizer Presents Results from Two Phase 3 TRUMENBA® (Meningococcal Group B Vaccine) Studies at the European Society for Paediatric Infectious Diseases Meeting
May 11, 2016 08:00 AM Pfizer Awards More Than $1 Million in Metastatic Breast Cancer Research Funding Through Breast Cancer: A Story Half Told Initiative
May 5, 2016 07:01 AM WAVE Life Sciences Enters Collaboration with Pfizer to Develop Genetically Targeted Therapies for the Treatment of Metabolic Diseases
May 3, 2016 06:45 AM PFIZER REPORTS FIRST-QUARTER 2016 RESULTS
Apr 28, 2016 12:00 PM Pfizer Hosts Annual Meeting of Shareholders
Apr 26, 2016 08:30 AM Bococizumab SPIRE-2 Cardiovascular Outcome Study Fully Enrolled
Apr 22, 2016 06:30 PM CHANTIX®/CHAMPIX® (varenicline) Results from the Largest Global Clinical Trial of Smoking Cessation Medicines Published in The Lancet
Apr 21, 2016 02:00 PM Pfizer Invites Public to Listen to Webcast of April 28 Annual Meeting of Shareholders
Apr 19, 2016 08:00 AM Pfizer Announces Positive Top-Line Results for Phase 3 PALOMA-2 Clinical Trial of IBRANCE® (palbociclib)
Apr 15, 2016 06:00 AM On the Latest BizWireTV Cars Get Night Vision and Healthy Eating Made More Accessible
Apr 7, 2016 10:47 AM A.M. Best Affirms Ratings of Blue Whale Re Ltd.
Apr 7, 2016 08:30 AM Pfizer Taps IBM for Research Collaboration to Transform Parkinson’s Disease Care
Apr 6, 2016 11:00 AM Pfizer Receives European Approval for New Multi-Dose Vial Presentation of Prevenar 13®
Apr 6, 2016 06:45 AM Allergan Reiterates Strong Standalone Growth Profile and Strategy Following Termination of Pfizer Transaction
Apr 6, 2016 06:45 AM Pfizer Announces Termination of Proposed Combination with Allergan
Apr 5, 2016 05:34 PM FDA Approves INFLECTRA™ (Biosimilar Infliximab), The First U.S. Biosimilar Monoclonal Antibody, For All Eligible Indications
Apr 5, 2016 09:30 AM Remedy Pharmaceuticals Appoints Dr. Thomas R. Zimmerman Jr. as Vice President, Medical Affairs
Apr 5, 2016 08:00 AM Merck and Pfizer Announce First Patient Treated in Phase III Combination Study with Avelumab and INLYTA® in Renal Cell Carcinoma
Apr 5, 2016 08:00 AM Merck KGaA, Darmstadt, Germany, and Pfizer Announce First Patient Treated in Phase III Combination Study with Avelumab and INLYTA® in Renal Cell Carcinoma
Apr 5, 2016 07:00 AM Pfizer Announces Positive Top-Line Results from the First Phase 3 Trial of Investigational Tofacitinib in Adults with Psoriatic Arthritis
Apr 4, 2016 07:05 PM Pfizer and Allergan Issue Statement
Apr 4, 2016 09:00 AM Cancer Metabolism Company Metabomed Completes $18 Million Series A Financing
Apr 1, 2016 08:00 AM Pfizer Announces Positive Topline Results from Second Phase 3 Lipid-Lowering Study Evaluating Bococizumab
Mar 31, 2016 04:29 PM Pfizer Inc. (NYSE: PFE) today issued the following statement:
Mar 30, 2016 12:41 PM Pfizer and Allergan Receive Request for Additional Information from Federal Trade Commission Regarding Proposed Combination
Mar 30, 2016 07:45 AM Bristol-Myers Squibb and Pfizer Announce Global Real-World Data Program and Present New Analyses of Eliquis (apixaban) at the American College of Cardiology’s 65th Annual Scientific Session
Mar 23, 2016 04:15 PM Pfizer Announces European Medicines Agency Accepted for Review Its Marketing Authorization Application for XELJANZ® (Tofacitinib Citrate) for the Treatment of Moderate to Severe Rheumatoid Arthritis
Mar 22, 2016 10:00 AM Pfizer Invites Public to View and Listen to Webcast of May 3 Conference Call with Analysts
Mar 22, 2016 08:30 AM Pfizer Joins The Human Vaccines Project To Help Decode The Immune System
Mar 18, 2016 11:00 AM Pfizer Announces Oral Tofacitinib, an Investigational JAK Inhibitor, Meets Primary and Key Secondary Endpoints in Two Pivotal Phase 3 Ulcerative Colitis Trials
Mar 16, 2016 08:00 AM Pfizer to Present New Data on Investigational Tofacitinib in Inflammatory Bowel Disease at the 11th Congress of ECCO
Mar 15, 2016 01:53 PM Pfizer Celebrates a Year of Achievements in 2015 Annual Review
Mar 11, 2016 01:10 PM XALKORI® (crizotinib) Approved by U.S. FDA for the Treatment of Patients with ROS1-Positive Metastatic Non-Small Cell Lung Cancer
Mar 9, 2016 08:00 AM New Survey Reveals Many Living with Symptoms of Diabetic Nerve Pain Are Undiagnosed Despite Severe and Constant Pain
Mar 9, 2016 06:45 AM Pfizer Commences $5 Billion Accelerated Share Repurchase
Mar 8, 2016 05:00 PM Pfizer Announces Publication of Study Results of BeneFIX® Coagulation Factor IX (Recombinant) Once-Weekly Prophylaxis for Hemophilia B
Mar 3, 2016 07:15 AM Merck, Pfizer and Verastem Announce Combination Trial of Avelumab and VS-6063 in Ovarian Cancer
Mar 3, 2016 07:00 AM Merck KGaA, Darmstadt, Germany, Pfizer and Verastem Announce Combination Trial of Avelumab and VS-6063 in Ovarian Cancer

Back to PFE Stock Lookup